Huayu Xiaowei Decoction for Treating Chronic Atrophic Gastritis in 76 Cases
|更新时间:2024-01-04
|
Huayu Xiaowei Decoction for Treating Chronic Atrophic Gastritis in 76 Cases
Chinese Journal of Experimental Traditional Medical FormulaeVol. 19, Issue 6, Pages: 342-344(2013)
作者机构:
作者简介:
基金信息:
DOI:
CLC:
Published:2013
稿件说明:
移动端阅览
WANG Ling-ling, JIA Yu-cong. Huayu Xiaowei Decoction for Treating Chronic Atrophic Gastritis in 76 Cases[J]. Chinese journal of experimental traditional medical formulae, 2013, 19(6): 342-344.
DOI:
WANG Ling-ling, JIA Yu-cong. Huayu Xiaowei Decoction for Treating Chronic Atrophic Gastritis in 76 Cases[J]. Chinese journal of experimental traditional medical formulae, 2013, 19(6): 342-344.DOI:
Huayu Xiaowei Decoction for Treating Chronic Atrophic Gastritis in 76 Cases
Objective: To observe the clinical efficacy of Huayu Xiaowei decoction (HXD) in treating chronic atrophic gastritis. Method: One hundred and fifty-one patients with chronic atrophic gastritis were randomly divided into two groups.The treatment group of 76 cases was given self-made HXD I dose daily.The control group was given vitacoenzyme tablets
1 g
tid.In the two groups
three months were selected as a course of treatment.The treatment was lasted for 2 courses.For evaluation of the clinical efficacy
changes in symptom scores and gastroscope images were investigated. Result: The total effective rate of the treatment group was 90.8%
and that of the control group was 69.3%.The comparison of the two groups was statistically significant(P<0.05).The symptom scores of stomach tingling
stomach fullness
facial darkness
anorexia and melena in the two groups showed statistical significances(P<0.05). Conclusion: HXD is effective for the treatment of chronic atrophic gastritis.The data provide a reference for colleagues working in the same area.
Excavation of New Prescription for Chronic Atrophic Gastritis and Its Verification of Syndrome Type of Deficiency of Stomach Yin
Application of Ferroptosis Regulation in Chronic Atrophic Gastritis Based on Spleen Deficiency and Turbid Toxin
Clinical Observation of Modified Huanglian Wendantang in Treatment of Cardiovascular Risk Factors in Patients with Metabolic Syndrome Under Guidance of Treating Disease before Its Onset
Clinical Observation of Guben Quyu Jiedu Prescription in Treating Nocturnal Hypoxemia of COPD Combined with OSAHS
Effect of Coptisine on PI3K/Akt/mTOR Signaling Pathway in Chronic Atrophic Gastritis Rats
Related Author
SHAO Changming
WANG Hongyu
XIE Shanshan
LIN Baitong
FAN Zhengyang
WANG Fang
LIN Yuyu
ZENG Binfang
Related Institution
Medical Department of Integrated Traditional Chinese and Western Medicine Hospital of Xinjiang Uygur Autonomous Region
College of Traditional Chinese Medicine, Xinjiang Medical University
Hebei University of Chinese Medicine
Hebei Hospital of Chinese Medicine
First Affiliated Hospital of Heilongjiang University of Chinese Medicine